Morning Movers 9/14: SLXP, S, KERX, ARIA, HDY Higher; ALXA, EE, SAH, CWTR Lower - Street Insider

Sign Up | Log In | What is SocialPicks?

Morning Movers 9/14: SLXP, S, KERX, ARIA, HDY Higher; ALXA, EE, SAH, CWTR Lower
Sep 14, 2009 01:33 PM UTC

Street Insider

Return	Risk
+9.67%	MID

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
SLXP	n/a

Via StreetInsider.com News Articles:

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) <font>54.4% HIGHER;</font> announced the successful outcome of two Phase 3, randomized, double-blind, placebo-controlled, multicenter trials, TARGET 1 and TARGET 2, designed to evaluate the efficacy and safety of rifaximin 550 mg TID in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS). Click here for the full report.

Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) <font>30% LOWER;</font> announced preliminary results from its 366 patient Phase 2b clinical trial of AZ-104 in patients with migraine headache. Both AZ-104 dose groups trended towards statistical significance, but the study did not meet its primary endpoint, which

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.